A new COVID-19 vaccine that fires proteins in the body that destroy the virus within two weeks is just a few months from human trials.

The ‘highly scalable’ vaccine is the first peer-reviewed antidote to theย coronavirusย that currently has much of the world in lockdown or isolation. Researchers from the University of Pittsburgh say the new treatment would be delivered through a ‘painless jab’ similar to the annual flu vaccine.
The team from the US have tested the vaccine on mice and estimate that it should be able to neutralize the deadly virus for at least a year.

The team from the US have tested the vaccine on mice and estimate that it should be able to neutralize the deadly virus for at least a year.

This is the first COVID-19 candidate vaccine that’s been scrutinized by independent scientists. The findings are published in The Lancet’s EBioMedicine journal.

SHARE